Latest Ratios: P/E Ratio 26.8x · EV/EBITDA 15.6x · ROE 21.9%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.4B | $952M | $575M | $518M | $198M | $239M | $236M | $257M | $306M | $296M | $266M |
| Enterprise Value | $1.4B | $957M | $622M | $529M | $226M | $234M | $216M | $241M | $302M | $299M | $262M |
| P/E Ratio → | 26.81 | 15.00 | 11.82 | 14.98 | 34.90 | 22.54 | 13.14 | 21.20 | 38.02 | 28.14 | 20.03 |
| P/S Ratio | 2.89 | 1.96 | 1.31 | 1.25 | 0.57 | 0.78 | 0.83 | 0.93 | 1.15 | 1.13 | 1.01 |
| P/B Ratio | 6.57 | 3.67 | 2.73 | 2.93 | 1.32 | 1.50 | 1.59 | 1.90 | 2.32 | 2.35 | 2.30 |
| P/FCF | 29.46 | 19.99 | 20.32 | 20.40 | — | — | 8.51 | 21.94 | — | 24.29 | 18.34 |
| P/OCF | 17.50 | 11.87 | 9.54 | 10.41 | 20.13 | 17.56 | 5.56 | 9.61 | 28.83 | 10.99 | 10.56 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.97 | 1.42 | 1.28 | 0.65 | 0.77 | 0.76 | 0.87 | 1.14 | 1.14 | 1.00 |
| EV / EBITDA | 15.60 | 10.60 | 8.62 | 9.35 | 9.46 | 8.59 | 8.84 | 10.16 | 10.56 | 10.69 | 9.51 |
| EV / EBIT | 20.64 | 13.94 | 12.08 | 14.63 | 32.65 | 16.59 | 9.18 | 15.93 | 19.45 | 19.39 | 17.05 |
| EV / FCF | — | 20.09 | 21.95 | 20.83 | — | — | 7.80 | 20.59 | — | 24.55 | 18.11 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.5% | 29.5% | 28.6% | 25.0% | 17.9% | 21.4% | 26.8% | 23.7% | 27.0% | 28.1% | 29.4% |
| Operating Margin | 14.0% | 14.0% | 12.1% | 9.9% | 3.0% | 4.3% | 3.7% | 3.8% | 6.0% | 5.8% | 5.9% |
| Net Profit Margin | 10.6% | 10.6% | 8.5% | 6.8% | 1.6% | 3.5% | 6.3% | 4.4% | 3.0% | 4.0% | 5.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.9% | 21.9% | 19.2% | 17.1% | 3.7% | 6.9% | 12.7% | 9.1% | 6.2% | 8.7% | 11.8% |
| ROA | 13.8% | 13.8% | 11.6% | 10.5% | 2.4% | 4.6% | 8.1% | 6.1% | 4.0% | 5.1% | 6.7% |
| ROIC | 19.7% | 19.7% | 17.8% | 16.8% | 4.7% | 6.9% | 6.4% | 6.3% | 9.2% | 9.5% | 10.4% |
| ROCE | 22.4% | 22.4% | 20.5% | 19.2% | 5.4% | 6.9% | 5.8% | 6.2% | 9.2% | 8.6% | 9.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.21 | 0.21 | 0.34 | 0.24 | 0.30 | 0.12 | 0.14 | 0.05 | 0.07 | 0.10 | 0.13 |
| Debt / EBITDA | 0.61 | 0.61 | 0.98 | 0.75 | 1.87 | 0.70 | 0.87 | 0.26 | 0.32 | 0.44 | 0.55 |
| Net Debt / Equity | — | 0.02 | 0.22 | 0.06 | 0.19 | -0.04 | -0.13 | -0.12 | -0.03 | 0.02 | -0.03 |
| Net Debt / EBITDA | 0.05 | 0.05 | 0.64 | 0.19 | 1.19 | -0.21 | -0.81 | -0.66 | -0.12 | 0.11 | -0.12 |
| Debt / FCF | — | 0.10 | 1.63 | 0.42 | — | — | -0.71 | -1.34 | — | 0.26 | -0.23 |
| Interest Coverage | 28.20 | 28.20 | 28.52 | 24.69 | 5.65 | 19.52 | 45.44 | 25.49 | 22.99 | 17.38 | 14.87 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.56 | 2.56 | 2.21 | 2.32 | 2.36 | 2.61 | 2.35 | 2.74 | 2.68 | 2.94 | 2.97 |
| Quick Ratio | 1.82 | 1.82 | 1.39 | 1.60 | 1.63 | 2.01 | 1.83 | 2.00 | 1.95 | 2.26 | 2.21 |
| Cash Ratio | 0.73 | 0.73 | 0.37 | 0.54 | 0.34 | 0.63 | 0.88 | 0.67 | 0.64 | 0.99 | 0.94 |
| Asset Turnover | — | 1.24 | 1.23 | 1.44 | 1.40 | 1.34 | 1.20 | 1.35 | 1.37 | 1.23 | 1.28 |
| Inventory Turnover | 6.64 | 6.64 | 5.76 | 7.27 | 8.04 | 10.16 | 8.68 | 8.75 | 8.62 | 8.34 | 7.96 |
| Days Sales Outstanding | — | 52.14 | 51.86 | 52.39 | 54.12 | 48.98 | 44.99 | 46.72 | 46.11 | 45.57 | 42.28 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.5% | 0.9% | 1.4% | 1.4% | 3.7% | 3.0% | 3.0% | 2.6% | 2.0% | 2.0% | 2.1% |
| Payout Ratio | 16.3% | 16.3% | 20.9% | 26.5% | 130.0% | 67.7% | 39.2% | 54.9% | 77.4% | 56.2% | 42.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.7% | 6.7% | 8.5% | 6.7% | 2.9% | 4.4% | 7.6% | 4.7% | 2.6% | 3.6% | 5.0% |
| FCF Yield | 3.4% | 5.0% | 4.9% | 4.9% | — | — | 11.8% | 4.6% | — | 4.1% | 5.5% |
| Buyback Yield | 0.2% | 0.2% | 0.5% | 0.2% | 6.0% | 1.3% | 2.3% | 0.1% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.7% | 1.1% | 1.8% | 1.6% | 9.7% | 4.3% | 5.3% | 2.6% | 2.0% | 2.0% | 2.1% |
| Shares Outstanding | — | $17M | $18M | $17M | $13M | $13M | $14M | $15M | $14M | $14M | $14M |
Energy cost volatility exposure
Based on reported figures, ODC trades at a P/E of 26.97, which appears to command a premium relative to its historical averages and broader industrial peers, suggesting that investors are pricing in the stability of its vertically integrated mineral business rather than pure growth.
The current forward P/E of 28.85 implies that the market expects sustained earnings growth, likely driven by the high-margin Amlan animal health segment. However, given the cyclical nature of the core sorbent business, this valuation may be vulnerable if the company fails to demonstrate consistent margin expansion in its B2B operations.
According to recent quarterly data, ROIC has fluctuated between 3.7% and 6.0% over the last ten quarters, indicating that the company's asset-heavy mineral extraction model struggles to consistently generate returns that significantly exceed the cost of capital in a high-inflation environment.
The downward trend in ROIC from 6.0% in 2025Q1 to 4.0% in 2026Q3 suggests that the company's recent capital investments have yet to yield the expected efficiency gains. Investors should monitor whether the ongoing investment in specialized mineral processing can eventually drive a structural improvement in return on invested capital.
As reported in financial statements, the cash conversion cycle has oscillated between 89 and 100 days over the past ten quarters, reflecting the inherent difficulty in managing inventory levels for bulk mineral products alongside fluctuating customer demand in the retail and industrial segments.
The persistent DIO and DSO levels suggest that the company maintains a conservative inventory buffer, which is prudent given the logistics-heavy nature of the business but ties up significant capital. This inefficiency in working capital management appears to be a structural feature of the company's supply chain rather than a temporary operational hurdle.
Based on the most recent quarterly filings, ODC maintains a current ratio of 3.28, which provides a substantial liquidity cushion that effectively insulates the company from short-term operational shocks or sudden spikes in energy-related input costs that often plague the specialty minerals sector.
The company's ability to maintain such high liquidity while operating in a capital-intensive industry is a testament to its conservative financial management. This strong position allows the firm to navigate cyclical downturns without the need for external financing, which is a significant competitive advantage compared to more leveraged peers.
Market participants frequently misapply standard commodity-based EV/EBITDA multiples to ODC, which obscures the value of its proprietary life-sciences IP and the scarcity of its mineral reserves, leading to an incomplete assessment of the company's true long-term earnings power and asset replacement value.
By treating the company as a simple mineral extractor, analysts overlook the high-margin potential of the Amlan segment, which functions more like a specialty chemical business. A more appropriate approach would involve a sum-of-the-parts valuation that separates the stable, cash-generative sorbent business from the higher-growth, IP-driven animal health portfolio.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ODC stock.
Oil-Dri Corporation of America's current P/E ratio is 26.8x. The historical average is 20.1x. This places it at the 83th percentile of its historical range.
Oil-Dri Corporation of America's current EV/EBITDA is 15.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.8x.
Oil-Dri Corporation of America's return on equity (ROE) is 21.9%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 9.0%.
Based on historical data, Oil-Dri Corporation of America is trading at a P/E of 26.8x. This is at the 83th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Oil-Dri Corporation of America's current dividend yield is 0.49% with a payout ratio of 16.3%.
Oil-Dri Corporation of America has 29.5% gross margin and 14.0% operating margin. Operating margin between 10-20% is typical for established companies.
Oil-Dri Corporation of America's Debt/EBITDA ratio is 0.6x, indicating low leverage. A ratio below 2x is generally considered financially healthy.